Vertex Pharmaceuticals, Inc. (VRTX)

431.45 -2.85 (-0.66%) USD  |  NASDAQ  |  Apr 07, 14:03
More

Vertex Pharmaceuticals EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for VRTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Amgen, Inc. Upgrade
Moderna, Inc. Upgrade
Eli Lilly & Co. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade